Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Survival in patients with glioblastoma at a first progression does not correlate with isocitrate dehydrogenase (IDH)1 gene mutation status.

Japanese journal of clinical oncology - 1 Jan 2021

Tabei Yusuke, Kobayashi Keiichi, Saito Kuniaki, Shimizu Saki, Suzuki Kaori, Sasaki Nobuyoshi, Shiokawa Yoshiaki, Nagane Motoo

Abstract excerpt

BACKGROUNDS: Mutations in the isocitrate dehydrogenase (IDH)1 gene are favourable prognostic factors in newly diagnosed diffuse gliomas, whereas it remains controversial in the recurrent glioblastoma setting. METHODS: A total of 171 patients with newly diagnosed glioblastoma, either 'primary' glioblastoma or 'secondary' glioblastoma, treated at Kyorin University Hospital or Japanese Red Cross Medical Center from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Glioblastoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Isocitrate Dehydrogenase

Share to Kaplan-Meier Estimate

Share to Multivariate Analysis

Share to Neoplasm Recurrence, Local

Share to O(6)-Methylguanine-DNA Methyltransferase

Share to Survival Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 32888020
DOI: 10.1093/jjco/hyaa162
PMCID: PMC7767982

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Survival in patients with glioblastoma at a first progression does not correlate with isocitrate dehydrogenase (IDH)1 gene mutation status.PMID 32888020Read ↗

The definition of primary and secondary glioblastoma.Semantic proximity Read ↗

Secondary Glioblastoma: Molecular and Clinical Factors That Affect Outcome After Malignant Progression of a Lower Grade Tumor.Semantic proximity Read ↗

IDH1 mutation of gliomas with long-term survival analysis.Semantic proximity Read ↗

Differential Predictors and Clinical Implications Associated With Long-Term Survivors in IDH Wildtype and Mutant GlioblastomaSemantic proximity Read ↗

Secondary glioblastomas with IDH1/2 mutations have longer glioma history from preceding lower-grade gliomas.Semantic proximity Read ↗

Accelerated progression of IDH mutant glioma after first recurrenceSemantic proximity Read ↗

Genetics and Epigenetics of Glioblastoma: Applications and Overall Incidence of IDH1 MutationSemantic proximity Read ↗

IDH1 mutations is prognostic marker for primary glioblastoma multiforme but MGMT hypermethylation is not prognostic for primary glioblastoma multiforme.Semantic proximity Read ↗

Isocitrate Dehydrogenase (IDH)1/2 Mutations as Prognostic Markers in Patients With Glioblastomas.Semantic proximity Read ↗

Predictors of Survival in Turkish Patients with Primary Glioblastoma.Semantic proximity Read ↗

Isocitrate dehydrogenase status and molecular subclasses of glioma and glioblastomaSemantic proximity Read ↗

Prognostic significance of IDH 1 mutation in patients with glioblastoma multiforme.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.